SCHEMBL15445779

SCHEMBL15445779

c1ccc(-n2c3ccc(-c4ccc5c(c4)c4cc(-c6cccc7ccccc67)ccc4n5-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3c3cc(-c4cccc5ccccc45)ccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MCL1 Q07820 2/20 0.43
ACMSD Q8TDX5 1/20 0.43
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGER4 P35408 1/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17789196 0.99 KDM4E (0.53) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL16171510 0.97 KDM4E (0.49) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL16521308 0.97 KDM4E (0.51) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL26887744 0.97 KDM4E (0.55) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL18717913 0.96 KDM4E (0.50) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL25941677 0.96 KDM4E (0.46) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL14805588 0.96 KDM4E (0.50) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL10130142 0.96 L3MBTL1 (0.50) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL18717927 0.96 KDM4E (0.53) KDM4EATML3MBTL1MCL1ACMSD
SCHEMBL14900796 0.96 KDM4E (0.47) KDM4EATML3MBTL1MCL1ACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10707434-B2 Organic electroluminescence element, and material for organic electroluminescence element IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 US disclosed
US-20190019972-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2019-01-17 US disclosed
US-9564595-B2 Bis-carbazole derivative and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2017-02-07 US disclosed
US-9564595-B2 Bis-carbazole derivative and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2017-02-07 US disclosed
US-20140306207-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-10-16 US disclosed
EP-2690093-A1 BIS-CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME Idemitsu Kosan Co., Ltd. (JP) 2014-01-29 EP disclosed
US-20140008633-A1 BIS-CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME MITSUI CHEMICALS, INC (JP) 2014-01-09 US disclosed
US-20140008633-A1 BIS-CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME MITSUI CHEMICALS, INC (JP) 2014-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190019972-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT LEF1, L1CAM, AGO2 KDM4E 3248/4885ATM 2324/4885L3MBTL1 1678/4885
US-10707434-B2 Organic electroluminescence element, and material for organic electroluminescence element LEF1, L1CAM, AGO2 KDM4E 3248/4885ATM 2324/4885L3MBTL1 1678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.